Amicus Therapeutics (FOLD) Payables: 2010-2025
Historic Payables for Amicus Therapeutics (FOLD) over the last 15 years, with Sep 2025 value amounting to $19.1 million.
- Amicus Therapeutics' Payables rose 41.70% to $19.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $60.4 million, marking a year-over-year decrease of 13.56%. This contributed to the annual value of $12.9 million for FY2024, which is 14.37% down from last year.
- Per Amicus Therapeutics' latest filing, its Payables stood at $19.1 million for Q3 2025, which was up 37.50% from $13.9 million recorded in Q2 2025.
- In the past 5 years, Amicus Therapeutics' Payables ranged from a high of $32.1 million in Q2 2024 and a low of $9.2 million during Q1 2024.
- In the last 3 years, Amicus Therapeutics' Payables had a median value of $14.5 million in 2025 and averaged $17.4 million.
- Examining YoY changes over the last 5 years, Amicus Therapeutics' Payables showed a top increase of 137.07% in 2024 and a maximum decrease of 63.11% in 2024.
- Quarterly analysis of 5 years shows Amicus Therapeutics' Payables stood at $21.5 million in 2021, then declined by 28.35% to $15.4 million in 2022, then dropped by 1.90% to $15.1 million in 2023, then fell by 14.37% to $12.9 million in 2024, then soared by 41.70% to $19.1 million in 2025.
- Its Payables stands at $19.1 million for Q3 2025, versus $13.9 million for Q2 2025 and $14.5 million for Q1 2025.